Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA059702-02
Application #
3203474
Study Section
Pathology B Study Section (PTHB)
Project Start
1993-05-01
Project End
1996-04-30
Budget Start
1994-03-15
Budget End
1994-04-30
Support Year
2
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Saint Louis University
Department
Type
Schools of Medicine
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63103
Margaryan, Naira V; Seftor, Elisabeth A; Seftor, Richard E B et al. (2017) Targeting the Stem Cell Properties of Adult Breast Cancer Cells: Using Combinatorial Strategies to Overcome Drug Resistance. Curr Mol Biol Rep 3:159-164
Khalkhali-Ellis, Zhila; Goossens, William; Margaryan, Naira V et al. (2014) Cleavage of Histone 3 by Cathepsin D in the involuting mammary gland. PLoS One 9:e103230
Tysnes, Berit B; Satran, Hege A; Mork, Sverre J et al. (2013) Age-Dependent Association between Protein Expression of the Embryonic Stem Cell Marker Cripto-1 and Survival of Glioblastoma Patients. Transl Oncol 6:732-41
Hardy, Katharine M; Booth, Brian W; Hendrix, Mary J C et al. (2010) ErbB/EGF signaling and EMT in mammary development and breast cancer. J Mammary Gland Biol Neoplasia 15:191-9
Watanabe, Kazuhide; Meyer, Matthew J; Strizzi, Luigi et al. (2010) Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells. Stem Cells 28:1303-14
Margaryan, Naira V; Strizzi, Luigi; Abbott, Daniel E et al. (2009) EphA2 as a promoter of melanoma tumorigenicity. Cancer Biol Ther 8:279-88
Costa, Fabricio F; Seftor, Elisabeth A; Bischof, Jared M et al. (2009) Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics 1:387-98
Strizzi, Luigi; Hardy, Katharine M; Seftor, Elisabeth A et al. (2009) Development and cancer: at the crossroads of Nodal and Notch signaling. Cancer Res 69:7131-4
Strizzi, Luigi; Postovit, Lynne-Marie; Margaryan, Naira V et al. (2009) Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention. Expert Rev Dermatol 4:67-78
(2009) Correction: Development and Cancer: At the Crossroads of Nodal and Notch Signaling Cancer Res 69:8526-8527

Showing the most recent 10 out of 63 publications